On December 29, 2020, Divine Ayat, LLC. submitted a Pre-IND to the Food and Drug Administration to begin non-clinical and clinical trials of its Fitra30 COVID-19 Protocol.
Divine Ayat’s Fitra30 COVID-19 Protocol
This protocol consists of three features:
1) The Milhu Shamsi Herbal Formulation (MSHF). MSHF is designed to prevent and treat COVID-19 by targeting internal mechanisms which act as conduits for COVID-19 infection.
2) Induction of autophagy through herbal medicine and intermittent fasting.
3) Divine Ayat’s Spiritual, Emotional, and Mental Rejuvenation Program (SEM-RP) . COVID-19 has greatly affected many lives around the world. The combination of uncertainty and quarantining is causing depression, anxiety, sleep problems, and psychological distress. Divine Ayat’s SMER Program is a 30-day guided meditation program designed to reduce stress.
Once funding is secured our first round of trials will consist of nonclinical studies of our "Milhu Shamsi" & "Autophagy Jumpstart Formulas" to determine the risks of the drugs and to support safe doses in humans.